Boston Scientific Corp (BSX)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$62.18

Buy

$62.98

arrow-up$0.70 (+1.13%)

Prices updated at 08 Apr 2026, 13:37 EDT

Prices minimum 15 mins delay

Prices in USD

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

S&P 500

-%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	16,747m	20,074m
	11,490m	13,853m
	3,002m	3,971m
	17.93	19.78
	1,854m	2,898m
	3,856m	5,102m
Sales, General and administrative	5,984m	6,887m
Interest expenses	305m	349m
Provision for income taxes	436m	493m
Operating expenses	8,488m	9,882m
Income before taxes	2,282m	3,385m
Net income available to common shareholders	1,853m	2,898m
	1.26	1.96
Net interest income	-198m	-320m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.25	1.94
Free cash flow per share	1.2762	2.43
Book value/share	14.0435	15.7755
Debt equity ratio	0.411943	0.459599

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	6,920m	8,794m
Current liabilities	6,399m	5,439m
Total capital	30,612m	35,244m
Total debt	11,147m	11,436m
Total equity	21,770m	24,232m
Total non current liabilities	-	-
Loans	8,842m	11,012m
Total assets	39,395m	43,673m
Total liabilities	-	-
Cash and cash equivalents	414m	1,965m
Common stock	1,475m	1,483m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	1,055m	606m
Cash dividends paid	-	-
	2,365m	3,404m
Investments (gains) losses	-5,687m	-2,640m
	606m	2,147m
Net income	-	-
	3,435m	4,534m
	-1,070m	-1,130m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.